Fil LTD Aurinia Pharmaceuticals Inc. Transaction History

Fil LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $4.45 Million - $8.27 Million	-250,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $2.66 Million - $5.73 Million	-243,233 Reduced 49.31%	250,000 $5.53 Million
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $185,290 - $269,041	18,529 Added 3.9%	493,233 $6.39 Million
Q1 2021 May 14, 2021	BUY	$12.3 - $18.73 $5.84 Million - $8.89 Million	474,704 New	474,704 $6.16 Million

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.